康平科技：10月24日召开董事会会议

Group 1 - The core point of the article is that Kangping Technology (SZ 300907) held its tenth temporary board meeting on October 24, 2025, to review the third quarter report for 2025 [1] - For the first half of 2025, Kangping Technology's revenue composition was 97.6% from power tools and 2.4% from other businesses [1] - As of the report, Kangping Technology has a market capitalization of 3.2 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine [1] - There is a contrast noted between the thriving secondary market and the cooling fundraising environment in the primary market for biomedicine [1]